Ncardia believes that stem cell technology helps to get better medicines to patients faster. We develop, produce and commercialize highly predictive human cellular assay systems for safety/efficacy testing. The cardiac product portfolio encompasses a broad panel of hiPSC-derived cardiac and neural cell types. We deliver the CardioPlate product line of quality controlled ready-to-use assay plates as well as working assay solutions and extensive support.

Nattermannallee 1 / S20
Cologne, 50829  Germany